nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—Dexamethasone—psoriatic arthritis	0.0909	0.0986	CbGbCtD
Apixaban—ABCB1—Methylprednisolone—psoriatic arthritis	0.0867	0.094	CbGbCtD
Apixaban—ABCG2—Methotrexate—psoriatic arthritis	0.0731	0.0792	CbGbCtD
Apixaban—CYP2C19—Prednisone—psoriatic arthritis	0.0651	0.0706	CbGbCtD
Apixaban—ABCB1—Betamethasone—psoriatic arthritis	0.0564	0.0611	CbGbCtD
Apixaban—ABCB1—Prednisolone—psoriatic arthritis	0.0556	0.0603	CbGbCtD
Apixaban—ABCB1—Prednisone—psoriatic arthritis	0.0525	0.057	CbGbCtD
Apixaban—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0519	0.0563	CbGbCtD
Apixaban—CYP3A5—Dexamethasone—psoriatic arthritis	0.0504	0.0546	CbGbCtD
Apixaban—CYP2C8—Dexamethasone—psoriatic arthritis	0.0484	0.0525	CbGbCtD
Apixaban—CYP2C19—Dexamethasone—psoriatic arthritis	0.0406	0.0441	CbGbCtD
Apixaban—CYP3A4—Triamcinolone—psoriatic arthritis	0.0394	0.0427	CbGbCtD
Apixaban—CYP2C9—Dexamethasone—psoriatic arthritis	0.0338	0.0366	CbGbCtD
Apixaban—CYP3A4—Betamethasone—psoriatic arthritis	0.0338	0.0366	CbGbCtD
Apixaban—CYP3A4—Prednisolone—psoriatic arthritis	0.0333	0.0361	CbGbCtD
Apixaban—ABCB1—Dexamethasone—psoriatic arthritis	0.0328	0.0356	CbGbCtD
Apixaban—CYP3A4—Prednisone—psoriatic arthritis	0.0315	0.0341	CbGbCtD
Apixaban—ABCB1—Methotrexate—psoriatic arthritis	0.0263	0.0286	CbGbCtD
Apixaban—CYP3A4—Dexamethasone—psoriatic arthritis	0.0196	0.0213	CbGbCtD
Apixaban—Melaena—Auranofin—psoriatic arthritis	0.00306	0.0394	CcSEcCtD
Apixaban—Conjunctival haemorrhage—Betamethasone—psoriatic arthritis	0.00256	0.0329	CcSEcCtD
Apixaban—Conjunctival haemorrhage—Dexamethasone—psoriatic arthritis	0.00256	0.0329	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Auranofin—psoriatic arthritis	0.00228	0.0293	CcSEcCtD
Apixaban—Haematuria—Auranofin—psoriatic arthritis	0.00167	0.0215	CcSEcCtD
Apixaban—Eye disorder—Auranofin—psoriatic arthritis	0.00147	0.0189	CcSEcCtD
Apixaban—Anaemia—Auranofin—psoriatic arthritis	0.00127	0.0163	CcSEcCtD
Apixaban—Petechiae—Prednisolone—psoriatic arthritis	0.00122	0.0156	CcSEcCtD
Apixaban—Petechiae—Triamcinolone—psoriatic arthritis	0.00112	0.0144	CcSEcCtD
Apixaban—Petechiae—Methylprednisolone—psoriatic arthritis	0.00112	0.0143	CcSEcCtD
Apixaban—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0011	0.0141	CcSEcCtD
Apixaban—Petechiae—Betamethasone—psoriatic arthritis	0.00101	0.013	CcSEcCtD
Apixaban—Petechiae—Dexamethasone—psoriatic arthritis	0.00101	0.013	CcSEcCtD
Apixaban—Contusion—Dexamethasone—psoriatic arthritis	0.000957	0.0123	CcSEcCtD
Apixaban—Contusion—Betamethasone—psoriatic arthritis	0.000957	0.0123	CcSEcCtD
Apixaban—Ecchymosis—Prednisolone—psoriatic arthritis	0.000904	0.0116	CcSEcCtD
Apixaban—Petechiae—Prednisone—psoriatic arthritis	0.000884	0.0114	CcSEcCtD
Apixaban—Haematemesis—Methotrexate—psoriatic arthritis	0.000874	0.0112	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.000835	0.0107	CcSEcCtD
Apixaban—Contusion—Prednisone—psoriatic arthritis	0.000833	0.0107	CcSEcCtD
Apixaban—Ecchymosis—Triamcinolone—psoriatic arthritis	0.000832	0.0107	CcSEcCtD
Apixaban—Ecchymosis—Methylprednisolone—psoriatic arthritis	0.00083	0.0107	CcSEcCtD
Apixaban—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.000768	0.00987	CcSEcCtD
Apixaban—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.000766	0.00985	CcSEcCtD
Apixaban—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.000766	0.00985	CcSEcCtD
Apixaban—Ecchymosis—Betamethasone—psoriatic arthritis	0.000755	0.0097	CcSEcCtD
Apixaban—Ecchymosis—Dexamethasone—psoriatic arthritis	0.000755	0.0097	CcSEcCtD
Apixaban—Petechiae—Methotrexate—psoriatic arthritis	0.000738	0.0095	CcSEcCtD
Apixaban—Rash—Auranofin—psoriatic arthritis	0.000706	0.00908	CcSEcCtD
Apixaban—Dermatitis—Auranofin—psoriatic arthritis	0.000705	0.00907	CcSEcCtD
Apixaban—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.000697	0.00896	CcSEcCtD
Apixaban—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.000697	0.00896	CcSEcCtD
Apixaban—Nausea—Auranofin—psoriatic arthritis	0.000665	0.00855	CcSEcCtD
Apixaban—Ecchymosis—Prednisone—psoriatic arthritis	0.000657	0.00845	CcSEcCtD
Apixaban—Diabetes mellitus—Prednisone—psoriatic arthritis	0.000607	0.0078	CcSEcCtD
Apixaban—Breast disorder—Methylprednisolone—psoriatic arthritis	0.000602	0.00774	CcSEcCtD
Apixaban—Melaena—Methotrexate—psoriatic arthritis	0.000593	0.00763	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.000588	0.00756	CcSEcCtD
Apixaban—Ecchymosis—Methotrexate—psoriatic arthritis	0.000549	0.00706	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.000528	0.00679	CcSEcCtD
Apixaban—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.000507	0.00652	CcSEcCtD
Apixaban—Haemoglobin—Prednisolone—psoriatic arthritis	0.000505	0.00649	CcSEcCtD
Apixaban—Haemorrhage—Prednisolone—psoriatic arthritis	0.000502	0.00646	CcSEcCtD
Apixaban—Epistaxis—Triamcinolone—psoriatic arthritis	0.000485	0.00624	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.000465	0.00598	CcSEcCtD
Apixaban—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000464	0.00597	CcSEcCtD
Apixaban—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000463	0.00596	CcSEcCtD
Apixaban—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000462	0.00594	CcSEcCtD
Apixaban—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000461	0.00593	CcSEcCtD
Apixaban—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000453	0.00582	CcSEcCtD
Apixaban—Eye disorder—Methylprednisolone—psoriatic arthritis	0.000431	0.00554	CcSEcCtD
Apixaban—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000421	0.00542	CcSEcCtD
Apixaban—Haemoglobin—Betamethasone—psoriatic arthritis	0.000421	0.00542	CcSEcCtD
Apixaban—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000419	0.00539	CcSEcCtD
Apixaban—Haemorrhage—Betamethasone—psoriatic arthritis	0.000419	0.00539	CcSEcCtD
Apixaban—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000418	0.00538	CcSEcCtD
Apixaban—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.000416	0.00535	CcSEcCtD
Apixaban—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000415	0.00534	CcSEcCtD
Apixaban—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.000407	0.00524	CcSEcCtD
Apixaban—Breast disorder—Methotrexate—psoriatic arthritis	0.000398	0.00512	CcSEcCtD
Apixaban—Syncope—Prednisolone—psoriatic arthritis	0.000392	0.00504	CcSEcCtD
Apixaban—Eye disorder—Dexamethasone—psoriatic arthritis	0.000392	0.00504	CcSEcCtD
Apixaban—Eye disorder—Betamethasone—psoriatic arthritis	0.000392	0.00504	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—psoriatic arthritis	0.000384	0.00494	CcSEcCtD
Apixaban—Angiopathy—Dexamethasone—psoriatic arthritis	0.00038	0.00489	CcSEcCtD
Apixaban—Angiopathy—Betamethasone—psoriatic arthritis	0.00038	0.00489	CcSEcCtD
Apixaban—Haemoglobin—Prednisone—psoriatic arthritis	0.000367	0.00472	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—psoriatic arthritis	0.000365	0.00469	CcSEcCtD
Apixaban—Syncope—Triamcinolone—psoriatic arthritis	0.000361	0.00464	CcSEcCtD
Apixaban—Syncope—Methylprednisolone—psoriatic arthritis	0.00036	0.00463	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000359	0.00461	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000357	0.00459	CcSEcCtD
Apixaban—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000353	0.00454	CcSEcCtD
Apixaban—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000353	0.00453	CcSEcCtD
Apixaban—Shock—Prednisolone—psoriatic arthritis	0.000351	0.00452	CcSEcCtD
Apixaban—Eye disorder—Prednisone—psoriatic arthritis	0.000341	0.00439	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000339	0.00436	CcSEcCtD
Apixaban—Angiopathy—Prednisone—psoriatic arthritis	0.000331	0.00426	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—psoriatic arthritis	0.00033	0.00424	CcSEcCtD
Apixaban—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000328	0.00422	CcSEcCtD
Apixaban—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000327	0.00421	CcSEcCtD
Apixaban—Syncope—Betamethasone—psoriatic arthritis	0.000327	0.00421	CcSEcCtD
Apixaban—Syncope—Dexamethasone—psoriatic arthritis	0.000327	0.00421	CcSEcCtD
Apixaban—Haematuria—Methotrexate—psoriatic arthritis	0.000324	0.00417	CcSEcCtD
Apixaban—Shock—Triamcinolone—psoriatic arthritis	0.000323	0.00415	CcSEcCtD
Apixaban—Shock—Methylprednisolone—psoriatic arthritis	0.000322	0.00414	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000321	0.00413	CcSEcCtD
Apixaban—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000321	0.00413	CcSEcCtD
Apixaban—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000321	0.00412	CcSEcCtD
Apixaban—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000321	0.00412	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—psoriatic arthritis	0.000321	0.00412	CcSEcCtD
Apixaban—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000318	0.00409	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—psoriatic arthritis	0.000307	0.00394	CcSEcCtD
Apixaban—Hypotension—Methylprednisolone—psoriatic arthritis	0.000306	0.00393	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—psoriatic arthritis	0.000305	0.00392	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000301	0.00387	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—psoriatic arthritis	0.000299	0.00385	CcSEcCtD
Apixaban—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000298	0.00383	CcSEcCtD
Apixaban—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000298	0.00383	CcSEcCtD
Apixaban—Anaemia—Prednisone—psoriatic arthritis	0.000294	0.00378	CcSEcCtD
Apixaban—Shock—Betamethasone—psoriatic arthritis	0.000293	0.00377	CcSEcCtD
Apixaban—Shock—Dexamethasone—psoriatic arthritis	0.000293	0.00377	CcSEcCtD
Apixaban—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000292	0.00376	CcSEcCtD
Apixaban—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000292	0.00376	CcSEcCtD
Apixaban—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000292	0.00375	CcSEcCtD
Apixaban—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000292	0.00375	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—psoriatic arthritis	0.000285	0.00367	CcSEcCtD
Apixaban—Syncope—Prednisone—psoriatic arthritis	0.000285	0.00366	CcSEcCtD
Apixaban—Loss of consciousness—Prednisone—psoriatic arthritis	0.000279	0.00359	CcSEcCtD
Apixaban—Hypotension—Betamethasone—psoriatic arthritis	0.000278	0.00358	CcSEcCtD
Apixaban—Hypotension—Dexamethasone—psoriatic arthritis	0.000278	0.00358	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—psoriatic arthritis	0.000277	0.00356	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—psoriatic arthritis	0.000276	0.00354	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000275	0.00354	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000269	0.00345	CcSEcCtD
Apixaban—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000263	0.00338	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000259	0.00333	CcSEcCtD
Apixaban—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000257	0.00331	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000257	0.00331	CcSEcCtD
Apixaban—Shock—Prednisone—psoriatic arthritis	0.000255	0.00328	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—psoriatic arthritis	0.000254	0.00327	CcSEcCtD
Apixaban—Skin disorder—Prednisone—psoriatic arthritis	0.000252	0.00324	CcSEcCtD
Apixaban—Anaemia—Methotrexate—psoriatic arthritis	0.000245	0.00316	CcSEcCtD
Apixaban—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000242	0.00311	CcSEcCtD
Apixaban—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000241	0.0031	CcSEcCtD
Apixaban—Dizziness—Prednisolone—psoriatic arthritis	0.000236	0.00303	CcSEcCtD
Apixaban—Rash—Prednisolone—psoriatic arthritis	0.000225	0.00289	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—psoriatic arthritis	0.000225	0.00289	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000225	0.00289	CcSEcCtD
Apixaban—Dizziness—Triamcinolone—psoriatic arthritis	0.000217	0.00279	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000217	0.00279	CcSEcCtD
Apixaban—Dizziness—Methylprednisolone—psoriatic arthritis	0.000217	0.00278	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000213	0.00273	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000212	0.00273	CcSEcCtD
Apixaban—Nausea—Prednisolone—psoriatic arthritis	0.000212	0.00273	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—psoriatic arthritis	0.000211	0.00271	CcSEcCtD
Apixaban—Rash—Triamcinolone—psoriatic arthritis	0.000207	0.00266	CcSEcCtD
Apixaban—Dermatitis—Triamcinolone—psoriatic arthritis	0.000207	0.00266	CcSEcCtD
Apixaban—Rash—Methylprednisolone—psoriatic arthritis	0.000206	0.00266	CcSEcCtD
Apixaban—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000206	0.00265	CcSEcCtD
Apixaban—Hypotension—Methotrexate—psoriatic arthritis	0.000203	0.0026	CcSEcCtD
Apixaban—Dizziness—Dexamethasone—psoriatic arthritis	0.000197	0.00253	CcSEcCtD
Apixaban—Dizziness—Betamethasone—psoriatic arthritis	0.000197	0.00253	CcSEcCtD
Apixaban—Nausea—Triamcinolone—psoriatic arthritis	0.000195	0.00251	CcSEcCtD
Apixaban—Nausea—Methylprednisolone—psoriatic arthritis	0.000195	0.0025	CcSEcCtD
Apixaban—Hypersensitivity—Prednisone—psoriatic arthritis	0.000191	0.00246	CcSEcCtD
Apixaban—Rash—Betamethasone—psoriatic arthritis	0.000188	0.00241	CcSEcCtD
Apixaban—Rash—Dexamethasone—psoriatic arthritis	0.000188	0.00241	CcSEcCtD
Apixaban—Dermatitis—Betamethasone—psoriatic arthritis	0.000188	0.00241	CcSEcCtD
Apixaban—Dermatitis—Dexamethasone—psoriatic arthritis	0.000188	0.00241	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000187	0.00241	CcSEcCtD
Apixaban—Nausea—Betamethasone—psoriatic arthritis	0.000177	0.00227	CcSEcCtD
Apixaban—Nausea—Dexamethasone—psoriatic arthritis	0.000177	0.00227	CcSEcCtD
Apixaban—Dizziness—Prednisone—psoriatic arthritis	0.000171	0.00221	CcSEcCtD
Apixaban—Rash—Prednisone—psoriatic arthritis	0.000164	0.0021	CcSEcCtD
Apixaban—Dermatitis—Prednisone—psoriatic arthritis	0.000163	0.0021	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00016	0.00205	CcSEcCtD
Apixaban—Nausea—Prednisone—psoriatic arthritis	0.000154	0.00198	CcSEcCtD
Apixaban—Dizziness—Methotrexate—psoriatic arthritis	0.000143	0.00184	CcSEcCtD
Apixaban—Rash—Methotrexate—psoriatic arthritis	0.000137	0.00176	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—psoriatic arthritis	0.000137	0.00176	CcSEcCtD
Apixaban—Nausea—Methotrexate—psoriatic arthritis	0.000129	0.00166	CcSEcCtD
